New Delhi: Pathology laboratory chain, Metropolis Healthcare ended the third quarter of fiscal year with a revenue of Rs 406 crore, up 26 per cent on year-on-yea (YoY) basis. Ebitda for the quarter ...
MORRIS PLAINS, N.J., Feb. 10, 2026 /PRNewswire/ -- Solstice Advanced Materials, (NASDAQ: SOLS), a global leader in high-performance specialty materials, today announced that its Metropolis Works, Ill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results